Bullfrog ai announces strategic collaboration with sygnature discovery to introduce bullfrog data networks™ to global biopharma clients

Gaithersburg, md., june 12, 2025 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced a strategic collaboration with sygnature discovery, a leading uk-based contract research organization (cro) specializing in drug discovery. through this collaboration, sygnature will introduce bullfrog data networks™—bullfrog's proprietary ai-driven data insights platform powered by the bfleap™ engine—to sygnature's global client base of relevant biopharma companies.
BFRG Ratings Summary
BFRG Quant Ranking